Anti-Wrinkle and Skin Moisture Efficacy of 7-MEGATM : A Randomized, Double-Blind, Placebo Comparative Clinical Trial

7-MEGATM is a food product made from purified Alaska pollack fish oil containing palmitoleic acid (16:1), commonly referred to as omega-7. We sought to quantitatively evaluate whether this substance inhibits skin aging. A total of 101 middle-aged females were randomly allocated to the intervention (N = 50) or placebo group (N = 51). Each participant was advised to take either 500 mg of 7-MEGATM or a placebo twice daily for 12 weeks. The primary outcomes were the degree of improvement in wrinkles and the degree of moisture filling after consumption for 12 weeks compared to baseline. The secondary outcomes were improvement in skin wrinkles; moisture changes at 4 and 8 weeks from baseline; changes in transdermal water loss, skin elasticity, the melanin index, the erythema index, and the Global Photo Damage Score. We found a significant improvement in skin wrinkles and elasticity at 12 weeks in the 7-MEGATM-consuming group compared to that in the placebo group; skin moisture, elasticity, and the melanin index were also improved. No supplement-related adverse reactions were observed and 7-MEGATM was identified as safe. 7-MEGATM was effective for human skin function in terms of wrinkles, moisture, elasticity, and melanin production and may be useful as a skin nutritional supplement.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:16

Enthalten in:

Nutrients - 16(2024), 2 vom: 09. Jan.

Sprache:

Englisch

Beteiligte Personen:

Sung, Hyun Kyung [VerfasserIn]
Kim, Tae Jeong [VerfasserIn]
Kim, Hyung Mook [VerfasserIn]
Youn, Sang Jun [VerfasserIn]
Choi, Yong [VerfasserIn]
Lee, Na Young [VerfasserIn]
Oh, Hyun Jeong [VerfasserIn]
Kwon, Hyuck Se [VerfasserIn]
Shin, Seon Mi [VerfasserIn]

Links:

Volltext

Themen:

7-MEGATM
Comparative Study
Journal Article
Melanins
Omega-7
Randomized Controlled Trial
Randomized controlled trial
Skin aging
Skin nutritional supplements

Anmerkungen:

Date Completed 31.01.2024

Date Revised 31.01.2024

published: Electronic

Citation Status MEDLINE

doi:

10.3390/nu16020212

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367475898